IFGA Labs is actively pursuing non-dilutive grant funding to accelerate clinical validation and pilot deployment of our ROME (Repeatable Objective Measurement of Eyetrack) platform. Primary targets include: NIH SBIR/STT...
Our methodology at IFGA Labs centers on ROME (Repeatable Objective Measurement of Eyetrack) — a rapid, non-invasive platform that leverages high-precision computer vision and eye-tracking to capture dynamic oculomotor da...